Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
CD4+ T Cells and Lactobacillus casei Control Relapsing Colitis Mediated by CD8+ T Cells
Journal of Immunology, 10/22/09
Hacini–Rachinel F et al. – The data demonstrate that CD4+ regulatory T cells exert a protective effect on colitis by controlling colitogenic effector/memory CD8+ T cells during the effector (symptomatic) phase of acute and relapsing colitis, respectively. Probiotics with natural adjuvant effects on mucosal regulatory T cells may represent a valuable approach to alleviate the colitogenic effect of Tc1–type CD8+ effectors.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Innate immune responses to influenza A H5N1: friend or foe
Trends in Immunology, 10/30/09
Mesenchymal Stem Cell Homing Capacity
Transplantation, 10/29/09
Genetics of food allergy
Current Opinion in Pediatrics, 10/23/09
Today in Gastrointestinal/Hepatic...keeping you current
Receive free subspecialty "5-minute updates" via email
Lactobacillus GG Improves Recovery in Infants with Blood in the Stools and Presumptive Allergic Colitis Compared with Extensively Hydrolyzed Formula Alone
The Journal of Pediatrics, 11/03/09
Certolizumab pegol for the treatment of Crohn's disease
Expert Review of Clinical Immunology, 11/19/09
Zinc and micronutrient combinations to combat gastrointestinal inflammation
Current Opinion in Clinical Nutrition & Metabolic Care, 10/23/09
Sponsor
Article Search
Sponsor


See Latest Articles


